PSI 2022 Conference

June 12-15, 2022 | Gothenburg, Sweden

We are pleased to announce that this year we will be joining PSI 2022 Conference, the principal annual event for statisticians in the pharmaceutical industry, as sponsors, exhibitors, and delegates.

This year, the conference will consist of a variety of plenary and parallel sessions, as well breakout discussion sessions, workshops, a poster session and the annual general meeting.

Don’t miss an opportunity to reconnect to the fellow industry experts!

Events
Category:
Published on:
May 27, 2022
Our delegates
Ilaria Speranza

Ilaria Speranza

Senior Biostatistician, Alira Health
Lisa Comarella

Lisa Comarella

Director, Biostatistics, Alira Health
Katell Bernois

Katell Bernois

Director, Statistical Consulting, Alira Health
Valerio Calvanese

Valerio Calvanese

Account Manager, Alira Health

Related news

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Events May 27, 2022
PSI 2022 Conference
We are pleased to announce that this year we will be joining PSI 2022 Conference, the principal annual event for statisticians in the pharmaceutical industry, as sponsors, exhibitors, and delegates.
Biometrics
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Publications March 22, 2022
Biometrics: Industry State of Affairs
We spoke with Katell Bernois, Director of Statistical Consulting at Alira Health, to understand the key trends that are changing the biometrics industry.
Biometrics
Publications March 11, 2022
Addressing Common CDISC Compliance Findings for Regulatory Submission
Learn from the team of industry CDISC experts how to explain common SDTM/ADAM issues to regulatory reviewers.
Biometrics
Publications March 8, 2022
Case Study: Effective Early Phase Oncology Study Design
Discover more about how to use Bayesian Optimal Interval Design to effectively design an Early Phase Oncology study.
Biometrics
Publications March 8, 2022
White Paper: The Sequential Parallel Comparison Design for Reducing Placebo Response
In this white paper, we will explore a two-stage adaptive design called the “Sequential Parallel Comparison Design” (SPCD) for enrichment of placebo non-responders.
Biometrics
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.